Protective effects of apocynin on cisplatin-induced ototoxicity in an auditory cell line and in zebrafish

Journal of Applied Toxicology

Volumn 33, Issue 2, 2013, Pages 125-133

  Choi, June ^a   Im, Gi Jung ^a   Chang, Jiwon ^a   Chae, Sung Won ^a   Lee, Seung Hoon ^a   Kwon, Soon Young ^a   Chung, Ah Young ^a   Park, Hae Chul ^a   Jung, Hak Hyun ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Apocynin; Cisplatin; HEI OC1 cells; Ototoxicity; Zebrafish

Indexed keywords

ANTIOXIDANT; APOCYNIN; CASPASE 3; CISPLATIN; PROTECTIVE AGENT; REACTIVE OXYGEN METABOLITE;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL LOSS; CONTROLLED STUDY; CORTI ORGAN; EAR PROTECTION; EMBRYO; ENZYME INHIBITION; HAIR CELL; IN VITRO STUDY; IN VIVO STUDY; NICK END LABELING; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; ZEBRA FISH;

ACETOPHENONES; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; APOPTOSIS; CASPASE 3; CELL CULTURE TECHNIQUES; CELL LINE; CELL SURVIVAL; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; GREEN FLUORESCENT PROTEINS; HAIR CELLS, AUDITORY; HEARING LOSS; IN SITU NICK-END LABELING; MICE; MICROSCOPY, FLUORESCENCE; NEURONS; REACTIVE OXYGEN SPECIES; ZEBRAFISH;

DANIO RERIO;

EID: 84871621410     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1729     Document Type: Article

References (43)

1. Barbieri SS, Cavalca V, Eligini S, Brambilla M, Caiani A, Tremoli E, Colli S. 2004. Apocynin prevents cyclooxygenase 2 expression in human monocytes through NADPH oxidase and glutathione redox-dependent mechanisms. Free Radic. Biol. Med. 37: 156-165.
2. Campbell KC, Rybak LP, Meech RP, Hughes L. 1996. d-Methionine provides excellent protection from cisplatin ototoxicity in the rat. Hear. Res. 102: 90-98.
3. Campbell KC, Larsen DL, Meech RP, Rybak LP, Hughes LF. 2003a. Glutathione ester but not glutathione protects against cisplatin-induced ototoxicity in a rat model. J. Am. Acad. Audiol. 14: 124-133.
4. Campbell KC, Meech RP, Rybak LP, Hughes LF. 2003b. The effect of d-methionine on cochlear oxidative state with and without cisplatin administration: mechanisms of otoprotection. J. Am. Acad. Audiol. 14: 144-156.
5. Cardinaal RM, de Groot JC, Huizing EH, Veldman JE, Smoorenburg GF. 2000. Histological effects of co-administration of an ACTH((4-9)) analogue, ORG 2766, on cisplatin ototoxicity in the albino guinea pig. Hear. Res. 144: 157-167.
6. Chan EC, Datla SR, Dilley R, Hickey H, Drummond GR, Dusting GJ. 2007. Adventitial application of the NADPH oxidase inhibitor apocynin in vivo reduces neointima formation and endothelial dysfunction in rabbits. Cardiovasc. Res. 75: 710-718.
7. Chirino YI, Sanchez-Gonzalez DJ, Martinez-Martinez CM, Cruz C, Pedraza-Chaverri J. 2008. Protective effects of apocynin against cisplatin-induced oxidative stress and nephrotoxicity. Toxicology 245: 18-23.
8. Chiu LL, Cunningham LL, Raible DW, Rubel EW, Ou HC. 2008. Using the zebrafish lateral line to screen for ototoxicity. J. Assoc. Res. Otolaryngol. 9: 178-190.
9. Cui C, Chen AF, Jiang Z, Wu Q, Lin J, Wen H, Zeng J. 2007. Inhibition of NAD(P)H oxidase reduces fibronectin expression in stroke-prone renovascular hypertensive rat brain. Clin. Exp. Pharmacol. Physiol. 34: 304-309.
10. Erdos B, Broxson CS, King MA, Scarpace PJ, Tumer N. 2006. Acute pressor effect of central angiotensin II is mediated by NAD(P)H-oxidase-dependent production of superoxide in the hypothalamic cardiovascular regulatory nuclei. J. Hypertens. 24: 109-116.
11. Feghali JG, Liu W, Van De Water TR. 2001. l-n-Acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity. Laryngoscope 111: 1147-1155.
12. Gracia-Sancho J, Lavina B, Rodriguez-Vilarrupla A, Brandes RP, Fernandez M, Bosch J, Garcia-Pagan JC. 2007. Evidence against a role for NADPH oxidase modulating hepatic vascular tone in cirrhosis. Gastroenterology 133: 959-966.
13. Im GJ, Chang JW, Choi J, Chae SW, Ko EJ, Jung HH. 2010. Protective effect of Korean red ginseng extract on cisplatin ototoxicity in HEI-OC1 auditory cells. Phytother. Res. 24: 614-621.
14. Kalinec GM, Webster P, Lim DJ, Kalinec F. 2003. A cochlear cell line as an in vitro system for drug ototoxicity screening. Audiol. Neurootol. 8: 177-189.
15. Kanegae MP, da Fonseca LM, Brunetti IL, Silva SO, Ximenes VF. 2007. The reactivity of ortho-methoxy-substituted catechol radicals with sulfhydryl groups: contribution for the comprehension of the mechanism of inhibition of NADPH oxidase by apocynin. Biochem. Pharmacol. 74: 457-464.
16. Kim CH, Kang SU, Pyun J, Lee MH, Hwang HS, Lee H. 2008. Epicatechin protects auditory cells against cisplatin-induced death. Apoptosis 13: 1184-1194.
17. Kirsch DG, Doseff A, Chau BN, Lim DS, de Souza-Pinto NC, Hansford R, Kastan MB, Lazebnik YA, Hardwick JM. 1999. Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c. J. Biol. Chem. 274: 21155-21161.
18. Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K, McGarry TJ, Kirschner MW, Koths K, Kwiatkowski DJ, et al. 1997. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 278: 294-298.
19. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. 1994. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371: 346-347.
20. Lee JE, Nakagawa T, Kim TS, Endo T, Shiga A, Iguchi F, Lee SH, Ito J. 2004. Role of reactive radicals in degeneration of the auditory system of mice following cisplatin treatment. Acta Otolaryngol. 124: 1131-1135.
21. Li G, Frenz DA, Brahmblatt S, Feghali JG, Ruben RJ, Berggren D, Arezzo J, Van De Water TR. 2001. Round window membrane delivery of l-methionine provides protection from cisplatin ototoxicity without compromising chemotherapeutic efficacy. Neurotoxicology 22: 163-176.
22. Li G, Sha SH, Zotova E, Arezzo J, Van de Water T, Schacht J. 2002. Salicylate protects hearing and kidney function from cisplatin toxicity without compromising its oncolytic action. Lab. Invest. 82: 585-596.
23. Matsui JI, Cotanche DA. 2004. Sensory hair cell death and regeneration: two halves of the same equation. Curr. Opin. Otolaryngol. Head Neck Surg. 12: 418-425.
24. Miller JM, Miller AL, Yamagata T, Bredberg G, Altschuler RA. 2002. Protection and regrowth of the auditory nerve after deafness: neurotrophins, antioxidants and depolarization are effective in vivo. Audiol. Neurootol. 7: 175-179.
25. Muijsers RB, van Den Worm E, Folkerts G, Beukelman CJ, Koster AS, Postma DS, Nijkamp FP. 2000. Apocynin inhibits peroxynitrite formation by murine macrophages. Br. J. Pharmacol. 130: 932-936.
26. Ou HC, Raible DW, Rubel EW. 2007. Cisplatin-induced hair cell loss in zebrafish (Danio rerio) lateral line. Hear. Res. 233: 46-53.
27. Pech V, Sikka SC, Sindhu RK, Vaziri ND, Majid DS. 2006. Oxidant stress and blood pressure responses to angiotensin II administration in rats fed varying salt diets. Am. J. Hypertens. 19: 534-540.
28. Raphael Y. 2002. Cochlear pathology, sensory cell death and regeneration. Br. Med. Bull. 63: 25-38.
29. Rugale C, Cordaillat M, Mimran A, Jover B. 2005. Prevention and reversal by enalapril of target organ damage in angiotensin II hypertension. J. Renin Angiotensin Aldosterone Syst. 6: 154-160.
30. Rybak LP. 2007. Mechanisms of cisplatin ototoxicity and progress in otoprotection. Curr. Opin. Otolaryngol. Head Neck Surg. 15: 364-369.
31. Rybak LP, Kelly T. 2003. Ototoxicity: bioprotective mechanisms. Curr. Opin. Otolaryngol. Head Neck Surg. 11: 328-333.
32. Rybak LP, Whitworth CA. 2005. Ototoxicity: therapeutic opportunities. Drug Discov. Today 10: 1313-1321.
33. Rybak LP, Ravi R, Somani SM. 1995. Mechanism of protection by diethyldithiocarbamate against cisplatin ototoxicity: antioxidant system. Fundam. Appl. Toxicol. 26: 293-300.
34. Rybak LP, Husain K, Evenson L, Morris C, Whitworth C, Somani SM. 1997. Protection by 4-methylthiobenzoic acid against cisplatin-induced ototoxicity: antioxidant system. Pharmacol. Toxicol. 81: 173-179.
35. Rybak LP, Whitworth C, Somani S. 1999. Application of antioxidants and other agents to prevent cisplatin ototoxicity. Laryngoscope 109: 1740-1744.
36. Rybak LP, Whitworth CA, Mukherjea D, Ramkumar V. 2007. Mechanisms of cisplatin-induced ototoxicity and prevention. Hear. Res. 226: 157-167.
37. Schweitzer VG, Dolan DF, Abrams GE, Davidson T, Snyder R. 1986. Amelioration of cisplatin-induced ototoxicity by fosfomycin. Laryngoscope 96: 948-958.
38. Takeno S, Harrison RV, Ibrahim D, Wake M, Mount RJ. 1994. Cochlear function after selective inner hair cell degeneration induced by carboplatin. Hear. Res. 75: 93-102.
39. Ton C, Parng C. 2005. The use of zebrafish for assessing ototoxic and otoprotective agents. Hear. Res. 208: 79-88.
40. Wake M, Takeno S, Ibrahim D, Harrison R. 1994. Selective inner hair cell ototoxicity induced by carboplatin. Laryngoscope 104: 488-493.
41. Wang J, Ladrech S, Pujol R, Brabet P, Van De Water TR, Puel JL. 2004. Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss. Cancer Res. 64: 9217-9224.
42. Watanabe K, Inai S, Jinnouchi K, Baba S, Yagi T. 2003. Expression of caspase-activated deoxyribonuclease (CAD) and caspase 3 (CPP32) in the cochlea of cisplatin (CDDP)-treated guinea pigs. Auris Nasus Larynx 30: 219-225.
43. Xiao T, Roeser T, Staub W, Baier H. 2005. A GFP-based genetic screen reveals mutations that disrupt the architecture of the zebrafish retinotectal projection. Development 132: 2955-2967.